| human | Q5 |
| P269 | IdRef ID | 079091121 |
| P213 | ISNI | 0000000139378754 |
| P496 | ORCID iD | 0000-0003-4705-2484 |
| P214 | VIAF ID | 203155230 |
| P185 | doctoral student | Nicaise Tuikue Ndam | Q44227537 |
| Gwladys Bertin | Q56382612 | ||
| Jean-Yves Le Hesran | Q56382619 | ||
| Rachida Tahar | Q56431368 | ||
| Agnes Aubouy | Q57252425 | ||
| P69 | educated at | Paris Descartes University | Q1155944 |
| P108 | employer | French National Institute of Health and Medical Research | Q1474517 |
| P735 | given name | Philippe | Q15727189 |
| Philippe | Q15727189 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q41529280 | 4-Aminoquinoline-sensitivity of Plasmodium falciparum in Madagascar. I. Study in two regions of the west coast |
| Q41529275 | 4-Aminoquinoline-sensitivity of Plasmodium falciparum in Madagascar. II. Study in two regions of the east coast |
| Q41529263 | 4-Aminoquinoline-sensitivity of Plasmodium falciparum in Madagascar: comparison of results and epidemiological perspectives |
| Q33828802 | A molecular epidemiological study of var gene diversity to characterize the reservoir of Plasmodium falciparum in humans in Africa |
| Q41919160 | Acquisition and decay of antibodies to pregnancy-associated variant antigens on the surface of Plasmodium falciparum-infected erythrocytes that protect against placental parasitemia. |
| Q39004073 | Acquisition of antibodies to variant antigens on the surface of Plasmodium falciparum-infected erythrocytes during pregnancy. |
| Q46979882 | Acquisition of antimalarial immunity in infants and children in Cameroon: follow-up of two cohorts. Presentation and preliminary results |
| Q35284671 | Activities of pefloxacin and ciprofloxacin against experimental malaria in mice |
| Q46373575 | Amodiaquine and chloroquine efficacy against Plasmodium falciparum in Madagascar |
| Q41912303 | Amodiaquine and sulfadoxine-pyrimethamine as treatment for chloroquine-resistant Plasmodium falciparum in Rwanda |
| Q43643657 | An in vitro microassay to assess the ability of Plasmodium falciparum-infected erythrocytes to bind to the human syncytiotrophoblast |
| Q24792921 | Analysis of IgG with specificity for variant surface antigens expressed by placental Plasmodium falciparum isolates |
| Q44565875 | Analysis of genetic diversity at the iron-containing superoxide dismutase locus in Plasmodium falciparum wild isolates |
| Q34537136 | Analysis of human antibodies to erythrocyte binding antigen 175 peptide 4 of Plasmodium falciparum |
| Q40007211 | Antibiotics usage in infants during the first 18 months of life in Benin: a population-based cohort study |
| Q36799341 | Antibodies to Pf155, a major antigen of Plasmodium falciparum: seroepidemiological studies in Haiti |
| Q45248021 | Antibodies to Plasmodium falciparum ring-infected erythrocyte surface antigen and P. falciparum and P. malariae circumsporozoite proteins: seasonal prevalence in Kenyan villages |
| Q41494323 | Antibodies to a Plasmodium falciparum blood-stage antigen as a tool for predicting the protection levels of two malaria-exposed populations |
| Q41500332 | Antibodies to the 4-mer repeat of the ring-infected erythrocyte surface antigen (Pf155/RESA) protect against Plasmodium falciparum malaria |
| Q46393508 | Antibodies to the PF155 antigen of Plasmodium falciparum: measurement by cell-ELISA and correlation with expected immune protection |
| Q43936474 | Antibodies to the ring-infected erythrocyte surface antigen and the circumsporozoite protein of Plasmodium falciparum in a rural community from Burkina Faso |
| Q40157751 | Antibodies to the ring-infected erythrocyte surface antigen of Plasmodium falciparum elicited by infection with Plasmodium malariae |
| Q39195292 | Antibody responses to Plasmodium falciparum: evolution according to the severity of a prior clinical episode and association with subsequent reinfection |
| Q41515227 | Antimalarial serology in 1987-1988 in the Highland Plateaux, the East coast and the South of Madagascar |
| Q41529333 | Application of an in vitro semi-microtest to the study of drug sensitivity of 66 Plasmodium falciparum isolates from 15 countries. |
| Q41509418 | Assessment of the protective value of antibodies to the Plasmodium falciparum ring-infected erythrocyte surface antigen (RESA): an epidemiologic study in Madagascar |
| Q36354336 | Beninese children with cerebral malaria do not develop humoral immunity against the IT4-VAR19-DC8 PfEMP1 variant linked to EPCR and brain endothelial binding |
| Q34479077 | Biomarkers of Plasmodium falciparum infection during pregnancy in women living in northeastern Tanzania. |
| Q57316621 | Bonnes Pratiques Cliniques dans les pays en développement : recommandations en termes d’application |
| Q33846633 | Can treatment of malaria be restricted to parasitologically confirmed malaria? A school-based study in Benin in children with and without fever |
| Q57316631 | Cellular responses to Loa loa experimental infection in mandrills (Mandrillus sphinx) vaccinated with irradiated infective larvae |
| Q91474679 | Changes in monocyte subsets are associated with clinical outcomes in severe malarial anaemia and cerebral malaria |
| Q27973894 | Characterization of an A-kinase anchoring protein-like suggests an alternative way of PKA anchoring in Plasmodium falciparum |
| Q48013901 | Chloroquine for treatment of falciparum malaria in Madagascar. |
| Q46857639 | Cloning and characterization of iron-containing superoxide dismutase from the human malaria species Plasmodium ovale, P. malariae and P. vivax. |
| Q30757681 | Combination of drug level measurement and parasite genotyping data for improved assessment of amodiaquine and sulfadoxine-pyrimethamine efficacies in treating Plasmodium falciparum malaria in Gabonese children |
| Q46261481 | Comparative analysis of 2 diagnostic methods of human loiasis: IgG4 serology and nested PCR |
| Q39000745 | Comparison of sulfadoxine-pyrimethamine, unsupervised artemether-lumefantrine, and unsupervised artesunate-amodiaquine fixed-dose formulation for uncomplicated plasmodium falciparum malaria in Benin: a randomized effectiveness noninferiority trial |
| Q36509858 | Computational Fluid Dynamic Simulations of Maternal Circulation: Wall Shear Stress in the Human Placenta and Its Biological Implications |
| Q37956479 | Congenital parasitic infections: a review |
| Q28730587 | Consequences of gestational malaria on birth weight: finding the best timeframe for intermittent preventive treatment administration |
| Q48033784 | Correlations between treatment outcome and both anti-MSP119 antibody response and erythrocyte-related genetic factors in Plasmodium falciparum malaria. |
| Q35545174 | Cytoadherence of Plasmodium falciparum to intercellular adhesion molecule 1 and chondroitin-4-sulfate expressed by the syncytiotrophoblast in the human placenta |
| Q46481957 | Cytoadherence of Plasmodium falciparum-infected erythrocytes in the human placenta |
| Q34116419 | Cytoadherence phenotype of Plasmodium falciparum-infected erythrocytes is associated with specific pfemp-1 expression in parasites from children with cerebral malaria |
| Q37153642 | DNA hybridization for assessment of response of Plasmodium falciparum to chloroquine therapy |
| Q33856250 | Demonstration of a high level of parasite population homology by quantification of Plasmodium falciparum alleles in matched peripheral, placental, and umbilical cord blood samples |
| Q38519513 | Developing vaccines to prevent malaria in pregnant women |
| Q39164327 | Development of cellular immune responses to Plasmodium falciparum blood stage antigens from birth to 36 months of age in Cameroon |
| Q54508319 | Dichlorquinazine (alpha 4-aminoquinoline) effective in vitro against chloroquine-resistant Plasmodium falciparum |
| Q34640524 | Differences in gene transcriptomic pattern of Plasmodium falciparum in children with cerebral malaria and asymptomatic carriers |
| Q44227448 | Differential adhesion-inhibitory patterns of antibodies raised against two major variants of the NTS-DBL2X region of VAR2CSA. |
| Q36478193 | Differential evolution of anti-VAR2CSA- IgG3 in primigravidae and multigravidae pregnant women infected by Plasmodium falciparum |
| Q46297609 | Differential protein expression profiles between Plasmodium falciparum parasites isolated from subjects presenting with pregnancy-associated malaria and uncomplicated malaria in Benin |
| Q48021094 | Distribution of IgG subclass antibodies specific for Plasmodium falciparum glutamate-rich-protein molecule in sickle cell trait children with asymptomatic infections |
| Q41919277 | Distribution of chloroquine and desethylchloroquine in blood, plasma and erythrocytes of healthy subjects and malaria patients. Assay using HPLC |
| Q38883564 | Dramatically decreased therapeutic efficacy of chloroquine and sulfadoxine-pyrimethamine, but not mefloquine, in southern Benin |
| Q41529257 | Drug sensitivity of Plasmodium falciparum in Madagascar. V. Study of the in vitro activity of quinine, mefloquine and halofantrine |
| Q33721310 | Dynamics in the cytoadherence phenotypes of Plasmodium falciparum infected erythrocytes isolated during pregnancy |
| Q39537046 | Dynamics of anti-VAR2CSA immunoglobulin G response in a cohort of senegalese pregnant women. |
| Q41512607 | Ecological factors in the renewed outbreak of malaria in Madagascar |
| Q38954403 | Effect of chloroquine prophylaxis during pregnancy on maternal haematocrit |
| Q40769688 | Efficacy of a 3-day oral regimen of a quinine-quinidine-cinchonine association (Quinimax) for treatment of falciparum malaria in Madagascar. |
| Q30981576 | Efficacy of permethrin-impregnated bed nets on malaria control in a hyperendemic area in Irian Jaya, Indonesia III. Antibodies to circumsporozoite protein and ring-infected erythrocyte surface antigen. |
| Q48000353 | Electroporation-mediated genetic vaccination for antigen mapping: application to Plasmodium falciparum VAR2CSA protein |
| Q47856419 | Epidemiology of malaria: research priorities (excluding entomology) |
| Q35014977 | Epistatic Interactions between apolipoprotein E and hemoglobin S Genes in regulation of malaria parasitemia. |
| Q33263953 | Epitope mapping and topographic analysis of VAR2CSA DBL3X involved in P. falciparum placental sequestration |
| Q55622193 | Erratum for Ibitokou et al., Submicroscopic Infections with Plasmodium falciparum during Pregnancy and Their Association with Circulating Cytokine, Chemokine, and Cellular Profiles. |
| Q43092767 | Erratum to: Beninese children with cerebral malaria do not develop humoral immunity against the IT4-VAR19-DC8 PfEMP1 variant linked to EPCR and brain endothelial binding |
| Q38295399 | Erythrocyte binding antigen (EBA-175) of Plasmodium falciparum: improved genotype determination by nested polymerase chain reaction. |
| Q41503898 | Evaluation of a nonisotopic DNA assay kit for diagnosing Plasmodium falciparum malaria in Madagascar |
| Q37178878 | Evolution of the levels of soluble interleukin-2 receptors during Plasmodium falciparum and P. vivax malaria |
| Q28534938 | Expression of the domain cassette 8 Plasmodium falciparum erythrocyte membrane protein 1 is associated with cerebral malaria in Benin |
| Q47858919 | Factors influencing resistance to reinfection with Plasmodium falciparum |
| Q39623231 | Fetal Growth Restriction Is Associated With Malaria in Pregnancy: A Prospective Longitudinal Study in Benin |
| Q48022082 | First-trimester Plasmodium falciparum infections display a typical "placental" phenotype |
| Q38943901 | Functional and immunological characterization of a duffy binding-like- gamma domain from Plasmodium falciparum erythrocyte membrane protein-1 expressed by a placental isolate |
| Q38343187 | Functional and immunological characterization of the var2CSA-DBL5epsilon domain of a placental Plasmodium falciparum isolate |
| Q47979297 | G6PD A-variant influences the antibody responses to Plasmodium falciparum MSP2. |
| Q38914963 | Genetic diversity of VAR2CSA ID1-DBL2Xb in worldwide Plasmodium falciparum populations: impact on vaccine design for placental malaria |
| Q39091624 | Gestational age-related changes in the peripheral blood cell composition of sub-Saharan African women |
| Q36756316 | Global occurrence of Plasmodium vivax-like human malaria parasite. |
| Q47881449 | HLA alleles in relation to specific immunity to liver stage antigen-1 from plasmodium falciparum in Gabon |
| Q36670321 | HLA class II haplotype studies bring molecular evidence for population affinity between Madagascans and Javanese. |
| Q33684063 | Heterozygous HbAC but not HbAS is associated with higher newborn birthweight among women with pregnancy-associated malaria. |
| Q38324821 | High level of var2csa transcription by Plasmodium falciparum isolated from the placenta |
| Q41647824 | High plasma levels of soluble endothelial protein C receptor are associated with increased mortality among children with cerebral malaria in Benin |
| Q38906295 | High prevalence of Plasmodium falciparum pfcrt K76T mutation in pregnant women taking chloroquine prophylaxis in Senegal |
| Q36940415 | High rates of parasite recrudescence following intermittent preventive treatment with sulphadoxine-pyrimethamine during pregnancy in Benin |
| Q91973028 | High uptake of Intermittent Preventive Treatment of malaria in pregnancy is associated with improved birth weight among pregnant women in Ghana |
| Q38303940 | Human genetic factors related to susceptibility to mild malaria in Gabon |
| Q47864025 | Human immune response in Plasmodium falciparum malaria. Synthetic peptides corresponding to known epitopes of the Pf155/RESA antigen induce production of parasite-specific antibodies in vitro |
| Q41511085 | Humoral and cell-mediated immune responses to the Plasmodium falciparum antigens PF155/RESA and CS protein: seasonal variations in a population recently reexposed to endemic malaria |
| Q46154114 | Humoral and cellular immune responses to synthetic peptides from the Plasmodium falciparum blood-stage antigen, Pf155/RESA, in Cameroonian women. |
| Q38973904 | IL-12 producing monocytes and IFN-gamma and TNF-alpha producing T-lymphocytes are increased in placentas infected by Plasmodium falciparum |
| Q47999224 | Identification of Id1-DBL2X of VAR2CSA as a key domain inducing highly inhibitory and cross-reactive antibodies |
| Q35783076 | Identification of a Major Dimorphic Region in the Functionally Critical N-Terminal ID1 Domain of VAR2CSA. |
| Q41491061 | IgG1 and IgG2 antibody responses to Plasmodium falciparum exoantigens correlate inversely and positively, respectively, to the number of malaria attacks |
| Q48036325 | Immune response to Plasmodium falciparum antigens in Cameroonian primigravidae: evolution after delivery and during second pregnancy |
| Q35852373 | Immunoglobulin response to Plasmodium falciparum RESA proteins in uncomplicated and severe malaria. |
| Q48005670 | Immunologic and biochemical alterations in severe falciparum malaria: relation to neurological symptoms and outcome. |
| Q37141041 | Immunological characteristics of malaria antibodies in two regions of Madagascar |
| Q38505960 | Immunological interactions between malaria and pregnancy |
| Q35043984 | Impact of pregnancy-associated malaria on infant malaria infection in southern Benin |
| Q39432086 | Impact of red blood cell polymorphisms on the antibody response to Plasmodium falciparum in Senegal |
| Q41921441 | In Vitro Study of Drug Sensitivity of Plasmodium Falciparum: Evaluation of a New Semi-Micro Test * |
| Q41916462 | In vitro activity of chloroquine, quinine, mefloquine and halofantrine against Gabonese isolates of Plasmodium falciparum. |
| Q36754071 | In vitro and in vivo potentiation of chloroquine against malaria parasites by an enantiomer of amlodipine |
| Q41916130 | In vitro susceptibility to a new antimalarial organometallic analogue, ferroquine, of Plasmodium falciparum isolates from the Haut-Ogooué region of Gabon |
| Q41521086 | In vivo and in vitro study of the chemosensitivity of Plasmodium falciparum in Madagascar--1982-1986 |
| Q39341627 | Increased risk of low birth weight in women with placental malaria associated with P. falciparum VAR2CSA clade |
| Q36411897 | Individual variation in levels of haptoglobin-related protein in children from Gabon |
| Q35845035 | Infants' Peripheral Blood Lymphocyte Composition Reflects Both Maternal and Post-Natal Infection with Plasmodium falciparum |
| Q37272658 | Infections with Plasmodium falciparum during pregnancy affect VAR2CSA DBL-5 domain-specific T cell cytokine responses |
| Q44815157 | Influence of carriage of hemoglobin AS and the Fc gamma receptor IIa-R131 allele on levels of immunoglobulin G2 antibodies to Plasmodium falciparum merozoite antigens in Gabonese children |
| Q33565468 | Influence of host factors and parasite biomass on the severity of imported Plasmodium falciparum malaria |
| Q35131357 | Influence of the timing of malaria infection during pregnancy on birth weight and on maternal anemia in Benin |
| Q33721891 | Insight into antigenic diversity of VAR2CSA-DBL5ε domain from multiple Plasmodium falciparum placental isolates |
| Q39195300 | Interferon-gamma responses are associated with resistance to reinfection with Plasmodium falciparum in young African children |
| Q41504897 | Is immunity to malaria really short-lived? |
| Q33612549 | Isotypic analysis of Plasmodium falciparum-specific antibodies and their relation to protection in Madagascar |
| Q44930822 | Kinetics of lymphocyte subsets from peripheral blood during a Plasmodium falciparum malaria attack |
| Q37243013 | Levels of cytokines in plasma during Plasmodium falciparum malaria attacks |
| Q44501141 | Longitudinal study of Plasmodium falciparum infection and immune responses in infants with or without the sickle cell trait. |
| Q41511397 | Longitudinal study of the cellular response to Pf155/RESA and circumsporozoite protein in Madagascar |
| Q36462673 | Malaria and gravidity interact to modify maternal haemoglobin concentrations during pregnancy. |
| Q34790559 | Malaria associated symptoms in pregnant women followed-up in Benin |
| Q48037007 | Malaria cellular immune responses in neonates from Cameroon |
| Q38492190 | Malaria during pregnancy: consequences and interventional perspectives |
| Q40779718 | Malaria in 1988 in a village of the Malagasy Highland Plateaux. Epidemiological findings |
| Q37036029 | Malaria modifies neonatal and early-life toll-like receptor cytokine responses |
| Q35623551 | Malaria prevention strategies |
| Q35572024 | Malaria, from natural to supernatural: a qualitative study of mothers' reactions to fever (Dienga, Gabon). |
| Q38954400 | Maternally transmitted antibodies to pregnancy-associated variant antigens on the surface of erythrocytes infected with Plasmodium falciparum: relation to child susceptibility to malaria |
| Q35868719 | Molecular aspects of Plasmodium falciparum Infection during pregnancy |
| Q35428566 | Molecular markers of resistance to sulphadoxine-pyrimethamine during intermittent preventive treatment of pregnant women in Benin |
| Q38973909 | Monocyte activation and T cell inhibition in Plasmodium falciparum-infected placenta |
| Q46973205 | Neopterin levels in plasma during a longitudinal study in an area endemic for malaria. |
| Q36668756 | Newly transmitted Plasmodium falciparum malaria in the central highland plateaux of Madagascar: assessment of clinical impact in a rural community |
| Q36073865 | Nrf2-driven CD36 and HO-1 gene expression in circulating monocytes correlates with favourable clinical outcome in pregnancy-associated malaria |
| Q39195303 | Parasite antigen-specific interleukin-10 and antibody reponses predict accelerated parasite clearance in Plasmodium falciparum malaria |
| Q35609294 | Parity-dependent recognition of DBL1X-3X suggests an important role of the VAR2CSA high-affinity CSA-binding region in the development of the humoral response against placental malaria |
| Q41508776 | Pefloxacin for falciparum malaria: only modest success |
| Q31108883 | Peripheral blood cell signatures of Plasmodium falciparum infection during pregnancy |
| Q43901426 | Persistence of cellular and humoral response to synthetic peptides from definedPlasmodium falciparumantigens |
| Q37368676 | PfHRP2 and PfLDH antigen detection for monitoring the efficacy of artemisinin-based combination therapy (ACT) in the treatment of uncomplicated falciparum malaria |
| Q34298328 | Placental cytokine and chemokine profiles reflect pregnancy outcomes in women exposed to Plasmodium falciparum infection |
| Q35328744 | Placental malaria-associated suppression of parasite-specific immune response in neonates has no major impact on systemic CD4 T cell homeostasis |
| Q46385452 | Plasma and in vitro levels of cytokines during and after a Plasmodium falciparum malaria attack in Gabon. |
| Q48009935 | Plasma levels of TNF-alpha soluble receptors correlate with outcome in human falciparum malaria. |
| Q37544298 | Plasmodium falciparum Polymorphisms associated with ex vivo drug susceptibility and clinical effectiveness of artemisinin-based combination therapies in Benin |
| Q37428342 | Plasmodium falciparum exposure in utero, maternal age and parity influence the innate activation of foetal antigen presenting cells. |
| Q39098829 | Plasmodium falciparum genotype population dynamics in asymptomatic children from Senegal |
| Q39004080 | Plasmodium falciparum induces a Th1/Th2 disequilibrium, favoring the Th1-type pathway, in the human placenta |
| Q34063668 | Plasmodium falciparum parasites causing cerebral malaria share variant surface antigens, but are they specific? |
| Q33946646 | Plasmodium falciparum population dynamics in a cohort of pregnant women in Senegal |
| Q33325481 | Plasmodium falciparum transcriptome analysis reveals pregnancy malaria associated gene expression |
| Q34571421 | Plasmodium falciparum variability and immune evasion proceed from antigenicity of consensus sequences from DBL6ε; generalization to all DBL from VAR2CSA. |
| Q41920979 | Plasmodium falciparum: drug sensitivity in vitro of isolates before and after adaptation to continuous culture |
| Q41552120 | Plasmodium falciparum: in vitro models of cytoadherence of infected erythrocytes and an analysis with eight different isolates on different target cells |
| Q37261950 | Plasmodium vivax malaria during pregnancy, Bolivia |
| Q36173275 | Possible association of the Plasmodium falciparum T1526C resa2 gene mutation with severe malaria |
| Q38954518 | Prediction of Plasmodium falciparum placental infection according to the time of infection during pregnancy |
| Q39257072 | Preferential expression of domain cassettes 4, 8 and 13 of Plasmodium falciparum erythrocyte membrane protein 1 in severe malaria imported in France |
| Q41534529 | Preliminary in vitro study of drug sensitivity of Plasmodium falciparum in Madagascar |
| Q41534508 | Preliminary study of the prevalence of malaria infestation in the Province of Tamatave |
| Q40251097 | Prevalence and factors related to antibiotic prescription in Benin: a school-based study |
| Q47830965 | Prevalence of and risk factors for anemia in young children in southern Cameroon. |
| Q39306364 | Prognostic indicators in adult cerebral malaria: a study in Burundi, an area of high prevalence of HIV infection. |
| Q35546075 | Protective Antibodies against Placental Malaria and Poor Outcomes during Pregnancy, Benin |
| Q37241837 | Protective value of elevated levels of gamma interferon in serum against exoerythrocytic stages of Plasmodium falciparum |
| Q36953353 | Proteomic analysis of Plasmodium falciparum parasites from patients with cerebral and uncomplicated malaria |
| Q47825252 | Purification of Pf155/RESA antigen from supernatants of in vitro Plasmodium falciparum cultures by continuous elution electrophoresis. |
| Q48005986 | Quantification of T cells reactive to Pf155/RESA peptides in Plasmodium falciparum-exposed individuals. |
| Q48021953 | Quantification of antibody-secreting lymphocytes that react with Pf155/RESA from Plasmodium falciparum: an ELISPOT assay for field studies |
| Q46220299 | R-II chloroquine-resistant falciparum malaria from Burundi. |
| Q51582925 | Receptor-binding studies of the DBLgamma domain of Plasmodium falciparum erythrocyte membrane protein 1 from a placental isolate. |
| Q57316623 | Recommandations pour la recherche clinique dans les pays en développement |
| Q39817841 | Reduced parasitemia observed with erythrocytes containing inositol hexaphosphate |
| Q37724246 | Reemergence of chloroquine-sensitive pfcrt K76 Plasmodium falciparum genotype in southeastern Cameroon |
| Q40562692 | Relationship between entomological inoculation rate, Plasmodium falciparum prevalence rate, and incidence of malaria attack in rural Gabon. |
| Q38499992 | Relationship between the intensity of Loa loa filariasis transmission and prevalence of infections |
| Q40750329 | Relationships between clinical protection and antibodies to Plasmodium falciparum RESA (ring-infected erythrocyte surface antigen) peptides |
| Q36284299 | Reliability of rapid diagnostic tests in diagnosing pregnancy-associated malaria in north-eastern Tanzania. |
| Q41521079 | Resistance of Plasmodium falciparum to 4-aminoquinolines. A review based on the Madagascar experience |
| Q48002721 | Ring-infected erythrocyte surface antigen (Pf/155RESA) induces tumour necrosis factor-alpha production |
| Q41946561 | Serological reactivity to the ring-infected erythrocyte surface antigen and circumsporozoite protein in gravid and nulligravid women infected with Plasmodium falciparum |
| Q40677404 | Short report: pefloxacin does not potentiate quinine efficacy against Plasmodium falciparum malaria |
| Q41512650 | Short-term oral cinchona alkaloids regimens for treatment of falciparum malaria in Madagascar |
| Q46366941 | Sickle cell trait carriage: imbalanced distribution of IgG subclass antibodies reactive to Plasmodium falciparum family-specific MSP2 peptides in serum samples from Gabonese children |
| Q47893995 | Site-based study on polymorphism of Plasmodium falciparum MSP-1 and MSP-2 genes in isolates from two villages in Central Africa |
| Q36933387 | Soluble intercellular adhesion molecule-1 and E-selectin levels in plasma of falciparum malaria patients and their lack of correlation with levels of tumor necrosis factor alpha, interleukin 1 alpha (IL-1 alpha), and IL-10. |
| Q41923140 | Standardisation of the in vitro chemosensitivity test for Plasmodium falciparum |
| Q27684051 | Structural and immunological correlations between the variable blocks of the VAR2CSA domain DBL6ε from two Plasmodium falciparum parasite lines |
| Q41476018 | Submicroscopic Plasmodium falciparum Infections Are Associated With Maternal Anemia, Premature Births, and Low Birth Weight |
| Q33743417 | Submicroscopic infections with Plasmodium falciparum during pregnancy and their association with circulating cytokine, chemokine, and cellular profiles. |
| Q41513965 | Sudden increase in number of isolates of Plasmodium falciparum resistant to chloroquine in Madagascar. |
| Q41921456 | Sulfadoxine-pyrimethamine for the treatment of Plasmodium falciparum malaria in Gabonese children |
| Q35805015 | Sulfadoxine/pyrimethamine intermittent preventive treatment for malaria during pregnancy |
| Q39154606 | Temporal variations in immune responses to conserved regions of Plasmodium falciparum merozoite surface proteins related to the severity of a prior malaria episode in Gabonese children |
| Q27300745 | The Influence of Sub-Unit Composition and Expression System on the Functional Antibody Response in the Development of a VAR2CSA Based Plasmodium falciparum Placental Malaria Vaccine |
| Q46326711 | The NTS-DBL2X region of VAR2CSA induces cross-reactive antibodies that inhibit adhesion of several Plasmodium falciparum isolates to chondroitin sulfate A. |
| Q30936416 | The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data |
| Q39133249 | The impact of IgG antibodies to recombinant Plasmodium falciparum 732var CIDR-1alpha domain in mothers and their newborn babies |
| Q43935921 | The multifactorial and multistage character of protective immunity to Plasmodium falciparum, naturally acquired by an indigenous population in Burkina Faso. |
| Q38928381 | The sickle cell trait is associated with enhanced immunoglobulin G antibody responses to Plasmodium falciparum variant surface antigens |
| Q33619319 | Towards the rational design of a candidate vaccine against pregnancy associated malaria: conserved sequences of the DBL6epsilon domain of VAR2CSA. |
| Q41508726 | Transmission and epidemiology of newly transmitted falciparum malaria in the central highland plateaux of Madagascar |
| Q37554737 | Usefulness of a biomarker to identify placental dysfunction in the context of malaria |
| Q39537054 | Variable adhesion abilities and overlapping antigenic properties in placental Plasmodium falciparum isolates |
| Q39133277 | Variants of Plasmodium falciparum erythrocyte membrane protein 1 expressed by different placental parasites are closely related and adhere to chondroitin sulfate A. |
| Q34078349 | What would PCR assessment change in the management of fevers in a malaria endemic area? A school-based study in Benin in children with and without fever. |
| Q68914840 | [In vitro action on Plasmodium falciparum of the serum of subjects having received 3 injectable forms of quinine by the intramuscular route] |
Search more.